Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting

Centers for Disease Control and Prevention (CDC)

Status: Completed

Conditions: Mycoplasma Pneumoniae

Treatments: Drug: Doxycycline treatment

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT00207584

CDC-NCHSTP-9997

Details and patient eligibility

About

This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Working at hospital facility where outbreak of Mycoplasma pneumoniae occured

Exclusion criteria

• Pregnant, on antiseizure medications, allergic to macrolide antibiotics